Kathryn Hayley Acquires 500 Shares of Concentrix Co. (NASDAQ:CNXC) Stock

Concentrix Co. (NASDAQ:CNXCGet Free Report) Director Kathryn Hayley bought 500 shares of the stock in a transaction on Wednesday, January 22nd. The shares were purchased at an average price of $50.22 per share, with a total value of $25,110.00. Following the acquisition, the director now owns 3,034 shares in the company, valued at approximately $152,367.48. This represents a 19.73 % increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Concentrix Stock Up 0.2 %

CNXC stock opened at $52.54 on Friday. The company has a market cap of $3.41 billion, a price-to-earnings ratio of 14.16, a P/E/G ratio of 0.70 and a beta of 0.63. Concentrix Co. has a twelve month low of $36.28 and a twelve month high of $95.04. The business has a 50 day moving average price of $44.66 and a two-hundred day moving average price of $54.25. The company has a quick ratio of 1.57, a current ratio of 1.42 and a debt-to-equity ratio of 1.17.

Concentrix (NASDAQ:CNXCGet Free Report) last released its earnings results on Wednesday, January 15th. The company reported $3.26 earnings per share for the quarter, beating the consensus estimate of $3.01 by $0.25. Concentrix had a net margin of 2.61% and a return on equity of 16.67%. The business had revenue of $2.45 billion during the quarter, compared to analysts’ expectations of $2.44 billion. During the same period last year, the business earned $3.36 earnings per share. The firm’s revenue was up 9.7% on a year-over-year basis. Analysts anticipate that Concentrix Co. will post 10.11 EPS for the current fiscal year.

Concentrix Cuts Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, February 11th. Stockholders of record on Friday, January 31st will be issued a $0.3328 dividend. The ex-dividend date is Friday, January 31st. This represents a $1.33 dividend on an annualized basis and a dividend yield of 2.53%. Concentrix’s payout ratio is 35.85%.

Hedge Funds Weigh In On Concentrix

A number of hedge funds and other institutional investors have recently bought and sold shares of CNXC. Copeland Capital Management LLC raised its stake in Concentrix by 32.9% in the fourth quarter. Copeland Capital Management LLC now owns 1,333,206 shares of the company’s stock valued at $57,688,000 after buying an additional 329,831 shares during the period. Pacer Advisors Inc. increased its holdings in shares of Concentrix by 24.9% during the 4th quarter. Pacer Advisors Inc. now owns 25,084 shares of the company’s stock worth $1,085,000 after acquiring an additional 4,997 shares during the last quarter. KBC Group NV raised its stake in Concentrix by 68.3% in the 4th quarter. KBC Group NV now owns 2,008 shares of the company’s stock valued at $87,000 after acquiring an additional 815 shares during the period. Impact Partnership Wealth LLC acquired a new stake in Concentrix during the 4th quarter valued at $323,000. Finally, Harbor Capital Advisors Inc. boosted its position in Concentrix by 46.6% during the fourth quarter. Harbor Capital Advisors Inc. now owns 31,756 shares of the company’s stock worth $1,374,000 after purchasing an additional 10,089 shares during the period. Institutional investors own 90.34% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently weighed in on CNXC. Canaccord Genuity Group reduced their price objective on Concentrix from $100.00 to $80.00 and set a “buy” rating for the company in a research report on Thursday, January 16th. Robert W. Baird began coverage on shares of Concentrix in a research note on Thursday, October 3rd. They set an “outperform” rating and a $70.00 price target for the company. Finally, Baird R W raised shares of Concentrix to a “strong-buy” rating in a research report on Thursday, October 3rd. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $75.00.

Get Our Latest Stock Analysis on Concentrix

Concentrix Company Profile

(Get Free Report)

Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.

Recommended Stories

Insider Buying and Selling by Quarter for Concentrix (NASDAQ:CNXC)

Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.